Latest AI and machine learning research in liver transplantation for healthcare professionals.
Streptomyces are renowned for their unparalleled capacity to produce bioactive natural products, making them prime candidates for industrial antibiotic manufacturing. However, Streptomyces lags behind E. coli and yeast in genetic tool development, as its promoters often constrained by narrow strength ranges, poor availability, and minimal diversity, hindering advanced synthetic biology application...
BACKGROUND: Spontaneous bacterial peritonitis (SBP) remains a life-threatening complication of liver cirrhosis, requiring accurate and rapid prediction. Albumin and leukocyte count reflect systemic inflammation and liver dysfunction; combining them into an Albumin-to-Leukocyte Ratio (ALR) may enhance early risk stratification. AIM: To evaluate the diagnostic value of the ALR for predicting SBP in ...
Cancer immunotherapy has revolutionised oncology by utilising immune-mediated mechanisms to achieve durable anti-tumour responses and long-term clinic...
Artificial intelligence (AI) has emerged as a transformative force in liver transplantation (LT), spanning patient selection, donor-recipient matching...
BACKGROUND: The global incidence of early-onset hepatocellular carcinoma (eHCC) is increasing significantly; however, specific risk prediction tools f...
Despite thorough characterizations of cellular compositions within the breast tumor microenvironment (TME), their implications for disease progression...
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is a highly heterogeneous malignancy with poor prognosis and variable response to therapy. E...
BACKGROUND: The early diagnosis of hepatorenal syndrome (HRS) is constrained by the reliance on serum creatinine, a biomarker with well-documented lim...
Contemporary clinical practice still produces unstructured data like free-text reports or scans, hindering automated interpretation by knowledge-based...
Hepatitis C virus (HCV) infection remains a leading cause of liver cirrhosis and hepatocellular carcinoma globally, affecting approximately 50 million...
Per- and polyfluoroalkyl substances (PFAS) are persistent pollutants linked to breast cancer (BC), but their role in perineural invasion (PNI) of trip...
G protein-coupled receptors (GPCRs) serve as central hubs in tumor signal transduction and microenvironment regulation. However, their therapeutic exp...
Breast cancer is highly heterogeneous,and different molecular subtypes exhibit significant variations in their response to immunotherapy.While signifi...
BACKGROUND: Inflammatory and infiltrative cardiomyopathies, including cardiac sarcoidosis, transthyretin amyloidosis, and autoimmune myocarditis, are ...
Immunotherapy has transformed cancer treatment but remains ineffective in many solid tumors, largely due to the immunosuppressive tumor microenvironme...
BACKGROUND: Identifying significant liver fibrosis (≥F2) is critical for initiating antiviral therapy in chronic hepatitis B (CHB). Chitinase-3-like p...
Hepatitis B virus (HBV) infection can lead to hepatocellular carcinoma, and HBV integration into the host genome is regularly observed in the liver of...
The discovery of selective immunosuppressants for T cell-mediated diseases like Ulcerative Colitis (UC) is a significant challenge. While traditional ...
Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis due to treatment resistance and an immunosuppressive, fibrotic microenvironment. Ferrop...
BACKGROUND: The intratumoral heterogeneity and immunosuppressive microenvironment of hepatocellular carcinoma (HCC) significantly limit therapeutic ef...